Error: Could not add to watchlist. X

Vernalis PLC

+ Watchlist
VNLPF:US
OTC US
Price not available for VNLPF:US
USD
Volume
0
Previous Close
0.71
52Wk Range
0.68 - 0.71
Volume
0
Previous Close
0.71
52Wk Range
0.68 - 0.71
Current P/E Ratio (TTM)
-
Earnings per Share (GBP) (TTM)
-
Market Cap (USD)
-
Shares Outstanding (m)
443.442
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Vernalis plc is a revenue generating development stage pharmaceutical company which has a broad pipeline of research and development programs. The Company is focused on developing products for the US prescription cough and cold market. The Company derives pipeline candidates both from collaborations with global pharmaceutical businesses and their own research activities.
ADDRESS
Oakdene Court
613 Reading Road
Winnersh, RG41 5UA
United Kingdom
PHONE
44-118-977-3133
  • Ian Garland
    Chief Executive Officer
  • David Mackney
    Chief Financial Officer
  • Tom Parker
    Senior VP:Commercial Operations
  • Pascal Borderies
    Senior VP:Medical Affairs
  • Kevin Kissane
    Secretary
Show More